Treatment of depression: Clinical aspects

Polish Journal of Pharmacology

Volumn 55, Issue 1, 2003, Pages 1-4

  Dudek, Dominika ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Depressive disorders; Pharmacotherapy; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALCOHOL CONSUMPTION; ANTICHOLINERGIC EFFECT; BEHAVIOR THERAPY; CARDIOTOXICITY; CLINICAL PRACTICE; COGNITIVE THERAPY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG OVERDOSE; ELECTROCONVULSIVE THERAPY; HUMAN; NAUSEA; NEUROTRANSMISSION; PATIENT COMPLIANCE; PHOTOTHERAPY; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; RESTLESSNESS; RISK ASSESSMENT; RISK FACTOR; SEXUAL DYSFUNCTION; SHORT SURVEY; SLEEP DEPRIVATION; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VOMITING;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PSYCHOTHERAPY;

EID: 0037248097     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Dudek D., Zieba A.: Depression in Coronary Artery Disease (Polish). Biblioteka Psychiatrii Polskiej, Kraków, 2001.
2. Greden J.F.: Recurrent depression. Its overwhelming burden. In: Treatment of Recurrent Depression. Review of Psychiatry, Vol. 20. Ed. Greden J.F., Washington, DC, American Psychiatric Publishing, 2001.
3. Judd L.L., Akiskal H.S., Maser J.D.: Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictors of rapid relapse. J. Affect. Disord., 1998, 50, 97-108.
4. Karasu T.B.: Toward a clinical model of psychotherapy for depression. II. An integrative and selective treatment approach. Amer. J. Psychiat., 1990, 147, 269-278.
5. Keller M.B., Boland R.J.: Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol. Psychiat., 1998, 44, 348-360.
6. Keller M.B., McCullough J.P., Klein D.N.: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med., 2000, 342, 1462-1470.
7. Kessler R.C., McGonagle K.A., Zhao S.: Lifetime and 12 month prevalence of DSM III R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiat., 1994, 51, 8-19.
8. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J.: The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Amer. J. Orthopsychiat., 1996, 66, 17-31.
9. Melfi C.A., Chawla A.J., Croghan T.W.: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch. Gen. Psychiat., 1998, 55, 1128-1132.
10. Murray C.J.L., Lopez A.D.: The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020. Vol. 1, Cambridge, MA, Harvard University Press, 1996.
11. Nierenberg A.A., Wright E.C.: Evolution of remission as the new standard in the treatment of depression. J. Clin. Psychiat., 1999, 60, Suppl. 22, 7-11.
12. Paykel E.S., Ramana R., Cooper Z.: Residual symptoms after partial remission: an important outcome in depression. Psychol. Med., 1995, 25, 1171-1180.
13. Puzyński S.: Depression and Affective Disorders (Polish). PZWL, Warszawa, 1999.
14. Regier D.A., Farmer M.E., Rae D.S.: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA, 1990, 264, 2511-2518.
15. Stahl S.M.: Psychopharmacology of Antidepressants. Martin Duniz, London, 1997.